MDM2 expression in EBV-infected nasopharyngeal carcinoma cells

Laboratory Investigation

Volumn 84, Issue 12, 2004, Pages 1547-1556

  Wu, Han Chung ^a,b   Lu, Tung Ying ^a   Lee, Jeng Jie ^a   Hwang, Jen Kuo ^a   Lin, Yu Ju ^a   Wang, Chung Kwe ^a,d   Lin, Chin Tarng ^a,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d Renai Hospital   (Taiwan)

Author keywords

Cotransfection of pmdm2 Luc; EBV infection; LMP1; mdm2 expression; Nasopharyngeal carcinoma; psv40 p53

Indexed keywords

IMMUNOGLOBULIN RECEPTOR; PROTEIN MDM2;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL POPULATION; CONTROLLED STUDY; ENDOCYTOSIS; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NASOPHARYNX CARCINOMA; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR BIOPSY; TUMOR CELL; UPREGULATION; VIRUS INFECTION; XENOGRAFT;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ENDOCYTOSIS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; MICE; MICE, SCID; NASOPHARYNGEAL NEOPLASMS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSPLANTATION, HETEROLOGOUS; ZINC FINGERS;

EID: 10044262203     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700183     Document Type: Article

References (29)

1. Waterhouse L, Muir C, Shanmugaratnam K, et al. Cancer Incidence in Five Continents, International Agency for Research on Cancer Scientific Publication 42, Vol. IV. International Agency for Research on Cancer: Lyon, 1982.
2. Klein G, Giovanella BC, Lindahl T, et al. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci USA 1974;71:4737-4741.
3. Niedobitek G, Hansmann ML, Herbst H, et al. Epstein-Barr virus and carcinoma: undifferentiated carcinoma but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991;165:17-24.
4. Armstrong RW, Armstrong MJ, Yu CM, et al. Salted fish and inhalants as risk factor for nasopharyngeal carcinoma in Malaysian Chinese. Cancer Res 1983;43:2967-2970.
5. Ho CK, Lo WCH, Huang PH, et al. Suspected nasopharyngeal carcinoma in three workers with long-term exposure to sulfuric acid vapor. Occup Environ Med 1999;56:426-428.
6. Lin CT, Wong CI, Chan WY, et al. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lab Invest 1990;62:713-724.
7. Lin CT, Chan WY, Chen W, et al. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab Invest 1993;68:716-727.
8. Lin CT, Chen W, Hsu MM, et al. Clonal versus polyclonal Epstein-Barr virus infection in nasopharyngeal carcinoma cell lines. Lab Invest 1997;76:793-798.
9. Lin CT, Dee AN, Chen W, et al. Association of Epstein-Barr virus, human papilloma virus and human cytomegalovirus in nine nasopharyngeal carcinoma cell lines. Lab Invest 1994;71:731-736.
10. Lin CT, Kao HJ, Lin JL, et al. Response of nasopharyngeal carcinoma cells to Epstein-Barr virus infection in vitro. Lab Invest 2000;80:1149-1160.
11. Lin CT, Lin CR, Tan GK, et al. The mechanism of Epstein-Barr virus infection in nasopharyngeal carcinoma cells. Am J Pathol 1997;150:1745-1756.
12. Wu HC, Lin YJ, Lee JJ, et al. Functional analysis of EBV in NPC cell. Lab Invest 2003;83:797-812.
13. Hwang JK, Lin CT. Colocalization of endogenous and exogenous p53 proteins in nasopharyngeal carcinoma cells. J Histochem Cytochem 1997;45:991-1003.
14. Effert P, McCoy R, Abdel-Hamid M, et al. Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol 1992;66:3768-3775.
15. Sun Y, Hegamyer G, Cheng YJ, et al. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc Natl Acad Sci USA 1992;89:6516-6520.
16. Lozano G, de Oca Luna RM. Minireview. MDM2 function. Biochim Biophys Acta 1998;1377, M 55-59.
17. Momand J, Wu HH, Dasgupta G. MDM2-master regulator of the p53 tumor suppressor protein. Gene 2000;242:15-29.
18. Piette J, Neel H, Marechal V. Mdm2: keeping p53 under control. Oncogene 1997;15:1001-1010.
19. Sigalas I, Calvert AH, Anderson JJ, et al. Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nat Med 1996;2:912-917.
20. Sixbey JW, Yao QY. Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 1992;255:1578-1580.
21. Sambrook J, Russell DW. Molecular Cloning. A laboratory Manual, Vol. 3, 3rd edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2001, Chapter 1b.
22. Teoh G, Urashima M, Ogata A, et al. MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells. Blood 1997;90:1982-1992.
23. Martin K, Trouche D, Hagemeier C, et al. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 1995;375:691-694.
24. Xiao ZX, Chen J, Levine AJ, et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 1995;375:694-698.
25. Takeshita H, Yoshizaki T, Miller WE, et al. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1c-terminal activation regions 1 and 2. J Virol 1999;73:5548-5555.
26. Qian W, Hu LF, Chen F, et al. Infrequent MDM2 gene amplification and absence of gross WAF1 gene alterations in nasopharyngeal carcinoma. Eur J Cancer B Oral Oncol 1995;31B:328-332.
27. ARF. Cell 2000;103:321-330.
28. Zhou BP, Liao Y, Xia W, et al. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat Cell Biol 2001;3:973-982.
29. Honda R, Yasuda H. Association of p19 (ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53. EMBO J 1999;18:22-27.